This American Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
8
0
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Wedbush analyst David Nierengarten downgraded the rating for Ikena Oncology, Inc. (NASDAQ:IKNA) from Outperform to Neutral, while slashing the price target from $8 to $2. Ikena Oncology shares closed at $1.33 on Tuesday. See how other analysts view this stock.
- Wells Fargo analyst Finian O’Shea downgraded Goldman Sachs BDC, Inc. (NYSE:GSBD) from Equal-Weight to Underweight and cut the price target from $15 to $14. Goldman Sachs BDC shares …
Full story available on Benzinga.com
Visited 8 times, 1 visit(s) today